ArticleOncogene2019

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.

Zachary A Yochum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.